|
AdvaMed: MDUFA Agreement Could Be “Game Changer” for FDA, Industry
A compromise reached by the FDA and device industry on medical device user fee reauthorization should benefit both parties and speed patient access to innovative technologies, AdvaMed President Stephen Ubl said.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives